Ninth Circuit Declines to Review FCA Public Disclosure Bar Ruling
Law360 – The Ninth Circuit has denied a request by Valeant Pharmaceuticals to review en banc its decision to revive an FCA suit against the company.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year